Skip to main content
. 2021 Jan 12;13(2):261–267. doi: 10.1002/dta.2992

TABLE 2.

In silico predicted activity for higenamine (predicted pXC50 ≥ 6)

Protein name Gene name Predicted pXC50 Predicted modality
Oestrogen receptor β ESR2 7.2 Not predicted
Adenylate cyclase type 5 ADCY5 6.9 Not predicted
5‐Hydroxytryptamine receptor 2A HTR2A 6.7 Agonist
β2‐Adrenoceptor ADRB2 6.6 Agonist
Oestrogen receptor ESR1 6.3 Not predicted
β1‐Adrenoceptor ADRB1 6 Agonist
β3‐Adrenoceptor ADRB3 6 Agonist